Annual CFO
-$60.35 M
-$13.76 M-29.53%
31 March 2022
Summary:
Sio Gene Therapies annual cash flow from operations is currently -$60.35 million, with the most recent change of -$13.76 million (-29.53%) on 31 March 2022. During the last 3 years, it has fallen by -$13.76 million (-29.53%).SIOX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$4.92 M
+$161.00 K+3.17%
31 December 2022
Summary:
Sio Gene Therapies quarterly cash flow from operations is currently -$4.92 million, with the most recent change of +$161.00 thousand (+3.17%) on 31 December 2022.SIOX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$36.51 M
+$15.68 M+30.05%
31 December 2022
Summary:
Sio Gene Therapies TTM cash flow from operations is currently -$36.51 million, with the most recent change of +$15.68 million (+30.05%) on 31 December 2022.SIOX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -29.5% | +76.1% | +30.8% |
| 5 y5 years | +55.0% | +62.4% | +40.3% |
SIOX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +29.5% | +8.5% | +705.0% |
Sio Gene Therapies Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | -$4.92 M(-3.2%) | -$36.51 M(-30.0%) |
| Sept 2022 | - | -$5.08 M(-41.4%) | -$52.19 M(-7.4%) |
| June 2022 | - | -$8.68 M(-51.3%) | -$56.38 M(-6.6%) |
| Mar 2022 | -$60.35 M(+29.5%) | -$17.82 M(-13.5%) | -$60.35 M(+14.4%) |
| Dec 2021 | - | -$20.61 M(+122.3%) | -$52.77 M(+22.2%) |
| Sept 2021 | - | -$9.27 M(-26.8%) | -$43.19 M(-5.6%) |
| June 2021 | - | -$12.65 M(+23.5%) | -$45.74 M(-1.8%) |
| Mar 2021 | -$46.59 M(-31.0%) | -$10.24 M(-7.1%) | -$46.59 M(-14.1%) |
| Dec 2020 | - | -$11.03 M(-6.7%) | -$54.26 M(-3.7%) |
| Sept 2020 | - | -$11.82 M(-12.5%) | -$56.32 M(-11.0%) |
| June 2020 | - | -$13.50 M(-24.6%) | -$63.24 M(-6.3%) |
| Mar 2020 | -$67.47 M(-49.7%) | -$17.91 M(+36.9%) | -$67.47 M(+10.3%) |
| Dec 2019 | - | -$13.09 M(-30.2%) | -$61.15 M(-25.0%) |
| Sept 2019 | - | -$18.75 M(+5.7%) | -$81.54 M(-9.9%) |
| June 2019 | - | -$17.73 M(+53.1%) | -$90.53 M(-32.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | -$134.21 M(-29.5%) | -$11.58 M(-65.4%) | -$134.21 M(-14.4%) |
| Dec 2018 | - | -$33.48 M(+20.7%) | -$156.82 M(-7.7%) |
| Sept 2018 | - | -$27.73 M(-54.8%) | -$169.94 M(-16.6%) |
| June 2018 | - | -$61.41 M(+79.6%) | -$203.84 M(+7.1%) |
| Mar 2018 | -$190.35 M(+69.8%) | -$34.20 M(-26.6%) | -$190.35 M(-3.6%) |
| Dec 2017 | - | -$46.59 M(-24.4%) | -$197.51 M(+9.7%) |
| Sept 2017 | - | -$61.64 M(+28.6%) | -$180.11 M(+27.3%) |
| June 2017 | - | -$47.92 M(+15.9%) | -$141.46 M(+26.2%) |
| Mar 2017 | -$112.11 M(+110.2%) | -$41.36 M(+41.7%) | -$112.11 M(+19.3%) |
| Dec 2016 | - | -$29.19 M(+26.9%) | -$93.97 M(+17.1%) |
| Sept 2016 | - | -$23.00 M(+23.9%) | -$80.21 M(+19.0%) |
| June 2016 | - | -$18.57 M(-20.0%) | -$67.38 M(+26.3%) |
| Mar 2016 | -$53.35 M | -$23.22 M(+50.4%) | -$53.35 M(+77.1%) |
| Dec 2015 | - | -$15.43 M(+51.9%) | -$30.13 M(+105.0%) |
| Sept 2015 | - | -$10.16 M(+124.1%) | -$14.70 M(+224.1%) |
| June 2015 | - | -$4.54 M | -$4.54 M |
FAQ
- What is Sio Gene Therapies annual cash flow from operations?
- What is the all time high annual CFO for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly cash flow from operations?
- What is the all time high quarterly CFO for Sio Gene Therapies?
- What is Sio Gene Therapies TTM cash flow from operations?
- What is the all time high TTM CFO for Sio Gene Therapies?
What is Sio Gene Therapies annual cash flow from operations?
The current annual CFO of SIOX is -$60.35 M
What is the all time high annual CFO for Sio Gene Therapies?
Sio Gene Therapies all-time high annual cash flow from operations is -$46.59 M
What is Sio Gene Therapies quarterly cash flow from operations?
The current quarterly CFO of SIOX is -$4.92 M
What is the all time high quarterly CFO for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly cash flow from operations is -$4.54 M
What is Sio Gene Therapies TTM cash flow from operations?
The current TTM CFO of SIOX is -$36.51 M
What is the all time high TTM CFO for Sio Gene Therapies?
Sio Gene Therapies all-time high TTM cash flow from operations is -$4.54 M